Press Releases

Perrigo is a leading global consumer-focused self-care company. Our vision is to make lives better by bringing “Quality, Affordable Self-Care Products” that consumers trust everywhere they are sold. The Company is a leading provider of health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed.

Month Year

Jun 20, 2016

Perrigo Divests Vitamins, Minerals & Supplements Business To IVC

Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has reached a definitive agreement to sell its U.S. Vitamins, Minerals & Supplements (VMS) business to International Vitamin...
Jun 16, 2016

Perrigo Announces FDA Approval Of The Generic Version Of Ofirmev® Acetaminophen Injection

Perrigo Company plc (NYSE: PRGO; TASE) today announced it has received final U.S. Food and Drug Administration ("FDA") approval for the generic version of Mallinckrodt Pharmaceuticals' Ofirmev®...
Jun 16, 2016

Perrigo Company to Present at the Oppenheimer 16th Annual Consumer Conference

Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chief Executive Officer John T. Hendrickson will present at the 16th Annual Oppenheimer Consumer Conference at 9:05 AM EDT on...
Jun 13, 2016

Perrigo Confirms First To File Patent Challenge For Generic Version Of Picato® Gel (0.015% And 0.05%)

Perrigo Company plc (NYSE: PRGO; TASE) announced that it has filed Abbreviated New Drug Applications (ANDAs) with the U.S. Food and Drug Administration (FDA) for ingenol mebutate gel (0.015% and...
May 31, 2016

Perrigo Announces FDA Approval And Launch Of The Store Brand Equivalent To Flonase®

Perrigo Company plc (NYSE: PRGO; TASE) and its partner West-Ward Pharmaceuticals Corp. today announced the U.S. Food and Drug Administration has approved, and that Perrigo has launched,...

Show per page

Perrigo Global Locations

Press Releases